EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?



Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?



Journal of Antimicrobial ChemoTherapy 42(5): 677-678




(PDF emailed within 0-6 h: $19.90)

Accession: 010270683

Download citation: RISBibTeXText

PMID: 9848461

DOI: 10.1093/jac/42.5.677



Related references

Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone. Journal of the Medical Association of Thailand 76(6): 314-318, 1993

New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?. ChemoTherapy 44(6): 427-435, 1998

Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet. Infectious Diseases 2(4): 231-242, 2002

A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients. American Journal of Clinical Oncology 17(5): 400-404, 1994

Protocol for a cooperative trial of empirical antibiotic treatment and early granulocyte transfusions in febrile neutropenic patients. European Journal of Cancer 13(6): 617-621, 1977

The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations. Journal of Antimicrobial ChemoTherapy 11 Suppl C: 57-63, 1983

An evaluation of empirical antibiotic therapy in febrile neutropenic patients. British Journal of Haematology 66(1): 137-140, 1987

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy. Antimicrobial Agents and ChemoTherapy 31(7): 971-977, 1987

Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia. Japanese Journal of Clinical Hematology 30(5): 644-649, 1989

Empirical antibiotic treatment of sepsis in non-neutropenic patients: Single agent or combination therapy?. Infection 22(1): 1-3, 1994

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. European Journal of Cancer 45(14): 2462-2472, 2009

Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer. Infection 30(1): 17-21, 2002

Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols. International Journal of Antimicrobial Agents 25(6): 469-473, 2005

An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clinical Microbiology and Infection 11 Suppl 5: 17-23, 2005